# Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis

> **NCT00142051** · PHASE2 · TERMINATED · sponsor: **Boston Children's Hospital** · enrollment: 18 (actual)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **DRUG:** nitric oxide
- **DRUG:** oxygen

## Key facts

- **NCT ID:** NCT00142051
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-04
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** 18 or 20 enrolled, stopped due to paucity of available participants
- **Last updated:** 2023-02-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00142051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00142051, "Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT00142051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*